Clinical Trial Update: The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated mobilized stem cell therapy using G-CSF and VEGF gene therapy in patients with stable severe angina due to ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Ischemic Heart Disease

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• VEGF gene therapy (vascular endothelial growth factor gene therapy)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Ischemic Heart Disease | Phase 1, Phase 2 | Status: COMPLETED